patent

The IP Battle Between Two Drug Titans Heats Up

August 31, 2009 Ainsley Brown Leave a comment

By: Ainsley Brown The Swiss pharmaceutical giant Novartis has launched suit in the English High Court against Glaxo Smith Kline (GSK) claiming that GSK has violated its intellectual property. This new action is far from being the opening salvos of this drug war; the two have already locked horns over the same matter. GSK last year sued Novartis in both

Commercial Awareness, Health, Intellectual Property, Litigation

Not So Splendid For The Maker Of Splenda: Tate & Lyle Loses Trade Commission Case.

April 16, 2009 Ainsley Brown Leave a comment

By: Ainsley Brown Tate & Lyle, the makers of Splenda, lost its appeal last week in the US International Trade Commission (ITC) in its bid to keep out an imported Chinese substitute to Splenda. The company initiated legal action in April of 2007 against a group of Chinese companies and six importers, after non-Splenda sucralose began appearing in the US

commodity, Food & Beverage, Intellectual Property, Litigation, Marketing/PR